Modulation of Cognitive Flexibility by Tyrosine Depletion and Transcranial Direct Current Stimulation

NCT ID: NCT03462303

Last Updated: 2018-09-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-02-12

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The dorsolateral prefrontal cortex (dlPFC) and dopamine (DA) have been implicated in the control of cognitive flexibility. However, while a great deal of what it is know regarding a causative relationship between cognitive flexibility and its neuronal underpinning comes from animal studies, human data have largely been correlational (i.e. imaging investigations). In a recent study, the current research group examined whether putative increases in dopamine levels through tyrosine administration and blockage of these by cathodal (i.e. inhibitory) transcranial direct current stimulation (tDCS) of the dlPFC could be causally related to cognitive flexibility as measured by task switching and reversal learning.

The next step involves finding a way of lowering dopamine concentrations while anodal (i.e. excitatory) stimulation of the dlPFC is applied and cognitive flexibility measured. One experimental approach to reduce global DA synthesis and transmission is through acute phenylalanine and tyrosine depletion (APTD). This dietary intervention involves the administration of an amino-acid mixture lacking in tyrosine and phenylalanine, which can be used to selectively lower DA synthesis in humans.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognitive Flexibility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

tDCS sham + balanced drink

Group Type PLACEBO_COMPARATOR

Sham tDCS and balanced drink

Intervention Type COMBINATION_PRODUCT

Transcranial direct current stimulation (sham) of the dlPFC in combination with a drink containing both tyrosine and phenylalanine.

tDCS sham + tyrosine depleted drink

Group Type EXPERIMENTAL

Sham tDCS and tyrosine depleted drink

Intervention Type COMBINATION_PRODUCT

Transcranial direct current stimulation (sham) of the dlPFC in combination with a tyrosine and phenylalanine free product.

tDCS anodal + balanced drink

Group Type EXPERIMENTAL

Anodal tDCS and balanced drink

Intervention Type COMBINATION_PRODUCT

Transcranial direct current stimulation (anodal) of the dlPFC in combination with a drink containing both tyrosine and phenylalanine.

tDCS anodal +tyrosine depleted drink

Group Type EXPERIMENTAL

Anodal tDCS and tyrosine depleted drink

Intervention Type COMBINATION_PRODUCT

Transcranial direct current stimulation (anodal) of the dlPFC in combination with a tyrosine and phenylalanine free product.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sham tDCS and tyrosine depleted drink

Transcranial direct current stimulation (sham) of the dlPFC in combination with a tyrosine and phenylalanine free product.

Intervention Type COMBINATION_PRODUCT

Anodal tDCS and tyrosine depleted drink

Transcranial direct current stimulation (anodal) of the dlPFC in combination with a tyrosine and phenylalanine free product.

Intervention Type COMBINATION_PRODUCT

Sham tDCS and balanced drink

Transcranial direct current stimulation (sham) of the dlPFC in combination with a drink containing both tyrosine and phenylalanine.

Intervention Type COMBINATION_PRODUCT

Anodal tDCS and balanced drink

Transcranial direct current stimulation (anodal) of the dlPFC in combination with a drink containing both tyrosine and phenylalanine.

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Either male or female
* You are aged between 18 and 30 years
* You are in good health
* You agree to fast overnight prior to testing

Exclusion Criteria

* Are suffering from cardiac, hepatic, renal, or neurological disorders
* Damaged or diseased skin on your face and scalp, or a sensitive scalp
* A history of alcohol or drug addiction, or severe psychiatric illness
* Are in drug treatment which may lower seizure threshold (i.e. epilepsy)
* You are pregnant
* Slept less than 6 hours prior to coming to the lab
* Suffer from phenylketonuria
* A history of or current experience of migraine or headaches
* A history of or current use of antidepressants
* A history of or current use of tyrosine supplements
* Consume more than five beverages containing caffeine per day
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sheffield Hallam University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Psychology labs

Sheffield, South Yorkshire, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SheffieldHallamAquili2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Efficacy of tDCS in Degenerative Ataxia
NCT07250321 ACTIVE_NOT_RECRUITING NA
Accelerating TMS for Cervical Dystonia
NCT06328114 ENROLLING_BY_INVITATION NA
Hippocampal Oscillations During Exploration
NCT07224191 NOT_YET_RECRUITING NA